Ameriprise’s Principal Exchange-Traded Funds Principal Healthcare Innovators ETF BTEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,653
Closed -$267K 4043
2021
Q4
$267K Buy
5,653
+354
+7% +$18.3K ﹤0.01% 3717
2021
Q3
$289K Buy
5,299
+1,576
+42% +$89.1K ﹤0.01% 3587
2021
Q2
$227K Buy
+3,723
New +$213K ﹤0.01% 3723
2021
Q1
Sell
-24,754
Closed -$1.43M 3908
2020
Q4
$1.43M Buy
+24,754
New +$1.34M ﹤0.01% 2930

Other funds holding BTEC

Ameriprise's BTEC Position: Q1 2022 in Review

Ameriprise sold out of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) in Q1 2022, closing a stake of 5,653 shares — an estimated $267K sold.

Ameriprise first reported a position in BTEC in Q4 2020 and held it in 4 quarters. The position peaked at $1.43M in Q4 2020. 31 funds tracked by Wall St. Rank hold BTEC as of Q1 2022.

  • Ameriprise reported no remaining Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position as of Q1 2022 after selling out during the quarter.
  • Ameriprise sold 5,653 Principal Exchange-Traded Funds Principal Healthcare Innovators ETF shares in Q1 2022, an estimated $267K.
  • Ameriprise first reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in Q4 2020 and held it in 4 quarters.
  • Ameriprise's Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position peaked at $1.43M in Q4 2020.
  • 31 funds tracked by Wall St. Rank held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF as of Q1 2022.

Based on Ameriprise's 13F filing for Q1 2022, filed 16 May 2022.